BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis. 2007;27:339-350. [PMID: 17979071 DOI: 10.1055/s-2007-991511] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang LY, Meng QH, Zou ZQ, Fan YC, Han J, Qi ZX, Ge J, Xu AL, Wang SK, Wang K. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2012;57:667-674. [PMID: 21984439 DOI: 10.1007/s10620-011-1930-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
2 Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci 2014;15:9184-208. [PMID: 24865485 DOI: 10.3390/ijms15069184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
3 Chung RT, Stravitz RT, Fontana RJ, Schiodt FV, Mehal WZ, Reddy KR, Lee WM. Pathogenesis of liver injury in acute liver failure. Gastroenterology 2012;143:e1-7. [PMID: 22796239 DOI: 10.1053/j.gastro.2012.07.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
4 Silva AKS, Peixoto CA. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. Cell Mol Life Sci. 2018;75:2951-2961. [PMID: 29789866 DOI: 10.1007/s00018-018-2838-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
5 Woodson SE, Holbrook MR. Infection of hepatocytes with 17-D vaccine-strain yellow fever virus induces a strong pro-inflammatory host response. J Gen Virol 2011;92:2262-71. [PMID: 21697351 DOI: 10.1099/vir.0.031617-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
6 Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr 2013;56:461-8. [PMID: 23287807 DOI: 10.1097/MPG.0b013e318284abb5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 59] [Article Influence: 14.6] [Reference Citation Analysis]
7 Woodson SE, Freiberg AN, Holbrook MR. Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology 2011;412:188-95. [PMID: 21277609 DOI: 10.1016/j.virol.2011.01.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
8 Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670-678. [PMID: 18666225 DOI: 10.1002/hep.22399] [Cited by in Crossref: 136] [Cited by in F6Publishing: 143] [Article Influence: 10.5] [Reference Citation Analysis]
9 Noor HB, Mou NA, Salem L, Shimul MFA, Biswas S, Akther R, Khan S, Raihan S, Mohib MM, Sagor MAT. Anti-inflammatory Property of AMP-activated Protein Kinase. Antiinflamm Antiallergy Agents Med Chem 2020;19:2-41. [PMID: 31530260 DOI: 10.2174/1871523018666190830100022] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Laskin D, Gardner C, Laskin J. Phagocytes. Comprehensive Toxicology. Elsevier; 2010. pp. 133-53. [DOI: 10.1016/b978-0-08-046884-6.00607-2] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Lin SH, Chung PH, Wu YY, Fung CP, Hsu CM, Chen LW. Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation. PLoS One 2017;12:e0177269. [PMID: 28493939 DOI: 10.1371/journal.pone.0177269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ren F, Zhou L, Zhang X, Wen T, Shi H, Xie B, Li Z, Chen D, Wang Z, Duan Z. Endoplasmic Reticulum Stress-Activated Glycogen Synthase Kinase 3β Aggravates Liver Inflammation and Hepatotoxicity in Mice with Acute Liver Failure. Inflammation 2015;38:1151-65. [DOI: 10.1007/s10753-014-0080-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
13 Chen SZ, Ling Y, Yu LX, Song YT, Chen XF, Cao QQ, Yu H, Chen C, Tang JJ, Fan ZC, Miao YS, Dong YP, Tao JY, Monga SPS, Wen W, Wang HY. 4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-α. Clin Transl Med 2021;11:e379. [PMID: 33931972 DOI: 10.1002/ctm2.379] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Federico A, D’Aiuto E, Borriello F, Barra G, Gravina AG, Romano M, De Palma R. Fat: A matter of disturbance for the immune system. World J Gastroenterol 2010; 16(38): 4762-4772 [PMID: 20939104 DOI: 10.3748/wjg.v16.i38.4762] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
15 Ishikawa S, Ikejima K, Yamagata H, Aoyama T, Kon K, Arai K, Takeda K, Watanabe S. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. Journal of Hepatology 2011;54:1195-204. [DOI: 10.1016/j.jhep.2010.08.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
16 Eriksson KK, Cervantes-Barragán L, Ludewig B, Thiel V. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-like supergroup. J Virol 2008;82:12325-34. [PMID: 18922871 DOI: 10.1128/JVI.02082-08] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 7.6] [Reference Citation Analysis]
17 Liu C, Chen J, Li E, Fan Q, Wang D, Li P, Li X, Chen X, Qiu S, Gao Z, Li H, Hu Y. The comparison of antioxidative and hepatoprotective activities of Codonopsis pilosula polysaccharide (CP) and sulfated CP. International Immunopharmacology 2015;24:299-305. [DOI: 10.1016/j.intimp.2014.12.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
18 Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World J Gastrointest Pathophysiol 2015; 6(4): 90-98 [PMID: 26600966 DOI: 10.4291/wjgp.v6.i4.90] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
19 Jiang TJ, Zhang JY, Li WG, Xie YX, Zhang XW, Wang Y, Jin L, Wang FS, Zhao M. Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection. Clin Immunol 2010;137:303-10. [PMID: 20943443 DOI: 10.1016/j.clim.2010.07.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
20 Yang HC, Cheng ML, Hua YS, Wu YH, Lin HR, Liu HY, Ho HY, Chiu DT. Glucose 6-phosphate dehydrogenase knockdown enhances IL-8 expression in HepG2 cells via oxidative stress and NF-κB signaling pathway. J Inflamm (Lond) 2015;12:34. [PMID: 25945076 DOI: 10.1186/s12950-015-0078-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
21 Zhu X, Xiao Z, Xu Y, Zhao X, Cheng P, Cui N, Cui M, Li J, Zhu X. Differential Impacts of Soybean and Fish Oils on Hepatocyte Lipid Droplet Accumulation and Endoplasmic Reticulum Stress in Primary Rabbit Hepatocytes. Gastroenterol Res Pract 2016;2016:9717014. [PMID: 27057162 DOI: 10.1155/2016/9717014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol. 2009;83:2796-2802. [PMID: 18842723 DOI: 10.1128/jvi.00996-08] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
23 Qu XJ, Xia X, Wang YS, Song MJ, Liu LL, Xie YY, Cheng YN, Liu XJ, Qiu LL, Xiang L, Gao JJ, Zhang XF, Cui SX. Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury. Food Chem Toxicol 2009;47:1710-5. [PMID: 19406199 DOI: 10.1016/j.fct.2009.04.032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
24 Van Linthout S, Miteva K, Tschöpe C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 2014;102:258-69. [PMID: 24728497 DOI: 10.1093/cvr/cvu062] [Cited by in Crossref: 258] [Cited by in F6Publishing: 249] [Article Influence: 36.9] [Reference Citation Analysis]
25 Marlowe J, Teo SS, Chibout SD, Pognan F, Moggs J. Mapping the epigenome--impact for toxicology. EXS 2009;99:259-88. [PMID: 19157065 DOI: 10.1007/978-3-7643-8336-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
26 Li G, Yuan L, Liu J, Zhao H. Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis". Hepatobiliary Surg Nutr 2016;5:509-10. [PMID: 28124010 DOI: 10.21037/hbsn.2016.12.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1065-1072. [PMID: 24236690 DOI: 10.1111/jgh.12459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wang YC, Yang KW, Lee TP, Lin CL, Liaw GW, Hung DZ, Kao CH, Chen WK, Yang TY. Increased risk of pyogenic liver abscess in patients with alcohol intoxication: A population-based retrospective cohort study. Alcohol 2017;64:23-8. [PMID: 28965652 DOI: 10.1016/j.alcohol.2017.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Ruan G, Zhang T, Li L, Zhang X, Shen Y, Tabata Y, Gao J. Hepatic-Targeted Gene Delivery Using Cationic Mannan Vehicle. Mol Pharmaceutics 2014;11:3322-9. [DOI: 10.1021/mp5000899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
30 Aller MA, Arias JL, Prieto I, Losada M, Arias J. Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis. Eur J Gastroenterol Hepatol 2010;22:651-61. [PMID: 19641467 DOI: 10.1097/MEG.0b013e32832e0a2f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
31 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 247] [Cited by in F6Publishing: 231] [Article Influence: 27.4] [Reference Citation Analysis]
32 Jampana SC, Khan R. Pathogenesis of alcoholic hepatitis: Role of inflammatory signaling and oxidative stress. World J Hepatol 2011; 3(5): 114-117 [PMID: 21731903 DOI: 10.4254/wjh.v3.i5.114] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
33 Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett. 2009;286:103-113. [PMID: 19070423 DOI: 10.1016/j.canlet.2008.10.048] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
34 Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(21): 2609-2618 [PMID: 22690069 DOI: 10.3748/wjg.v18.i21.2609] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 104] [Article Influence: 12.4] [Reference Citation Analysis]
35 Koletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care. 2010;13:321-326. [PMID: 20393276 DOI: 10.1097/mco.0b013e3283385407] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 6.2] [Reference Citation Analysis]
36 French SW, Bardag-Gorce F, French BA, Li J, Oliva J. The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Exp Mol Pathol 2011;91:653-9. [PMID: 21820428 DOI: 10.1016/j.yexmp.2011.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
37 Jiao M, Ren F, Zhou L, Zhang X, Zhang L, Wen T, Wei L, Wang X, Shi H, Bai L. Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway. Cell Death Dis. 2014;5:e1397. [PMID: 25165883 DOI: 10.1038/cddis.2014.361] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 8.7] [Reference Citation Analysis]
38 Poelstra K, Prakash J, Beljaars L. Drug targeting to the diseased liver. Journal of Controlled Release 2012;161:188-97. [DOI: 10.1016/j.jconrel.2012.02.011] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 11.2] [Reference Citation Analysis]
39 Wondimu Z, Santodomingo-Garzon T, Le T, Swain MG. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am J Pathol. 2010;177:2334-2346. [PMID: 20847291 DOI: 10.2353/ajpath.2010.100028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
40 Liu M, Zhang C. The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases. Front Immunol 2017;8:695. [PMID: 28659927 DOI: 10.3389/fimmu.2017.00695] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
41 Gao Y, Theng SS, Mah WC, Lee CG. Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity. Biol Open 2015;4:961-9. [PMID: 26142316 DOI: 10.1242/bio.011189] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
42 Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9:7204-18. [PMID: 29467962 DOI: 10.18632/oncotarget.23208] [Cited by in Crossref: 821] [Cited by in F6Publishing: 737] [Article Influence: 205.3] [Reference Citation Analysis]
43 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg.2011.02.005] [Cited by in Crossref: 525] [Cited by in F6Publishing: 520] [Article Influence: 52.5] [Reference Citation Analysis]
45 Rafe T, Shawon PA, Salem L, Chowdhury NI, Kabir F, Bin Zahur SM, Akhter R, Noor HB, Mohib MM, Sagor MAT. Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases. Curr Pharm Des 2019;25:1345-71. [PMID: 30968773 DOI: 10.2174/1381612825666190410153307] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
46 Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-54. [PMID: 18471544 DOI: 10.1053/j.gastro.2008.03.002] [Cited by in Crossref: 351] [Cited by in F6Publishing: 325] [Article Influence: 27.0] [Reference Citation Analysis]
47 Lin J, Fang T, Zhu M, Xu X, Zhang J, Zheng S, Jing C, Zhang M, Liu B, Zhang B. Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma. Cancer Manag Res 2019;11:9107-19. [PMID: 31802940 DOI: 10.2147/CMAR.S198959] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
48 Abutaleb A, Sherman KE. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatol Int 2018;12:500-9. [PMID: 30238230 DOI: 10.1007/s12072-018-9896-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
49 Mehta AJ, Joshi PC, Fan X, Brown LA, Ritzenthaler JD, Roman J, Guidot DM. Zinc supplementation restores PU.1 and Nrf2 nuclear binding in alveolar macrophages and improves redox balance and bacterial clearance in the lungs of alcohol-fed rats. Alcohol Clin Exp Res. 2011;35:1519-1528. [PMID: 21447000 DOI: 10.1111/j.1530-0277.2011.01488.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
50 Chen R, Hou W, Zhang Q, Kang R, Fan XG, Tang D. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357-366. [PMID: 24306421 DOI: 10.2119/molmed.2013.00099] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
51 Ludwig JM, Zhang Y, Chamulitrat W, Stremmel W, Pathil A. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury. PLoS One. 2018;13:e0197836. [PMID: 29795632 DOI: 10.1371/journal.pone.0197836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Han Z, Zhu T, Liu X, Li C, Yue S, Liu X, Yang L, Yang L, Li L. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. Hepatology 2012;56:350-60. [PMID: 22371273 DOI: 10.1002/hep.25672] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
53 Song X, Gao X, Wang Y, Raja R, Zhang Y, Yang S, Li M, Yao Z, Wei L. HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages. Front Immunol 2021;12:654998. [PMID: 34531848 DOI: 10.3389/fimmu.2021.654998] [Reference Citation Analysis]
54 Yu S, Zhou X, Xiang H, Wang S, Cui Z, Zhou J. Resveratrol Reduced Liver Damage After Liver Resection in a Rat Model by Upregulating Sirtuin 1 (SIRT1) and Inhibiting the Acetylation of High Mobility Group Box 1 (HMGB1). Med Sci Monit 2019;25:3212-20. [PMID: 31041919 DOI: 10.12659/MSM.913937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Chastre A, Bélanger M, Beauchesne E, Nguyen BN, Desjardins P, Butterworth RF. Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications. PLoS One. 2012;7:e49670. [PMID: 23166746 DOI: 10.1371/journal.pone.0049670] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
56 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
57 Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, Miftode E. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis 2015;34:2313-24. [PMID: 26440041 DOI: 10.1007/s10096-015-2501-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
58 Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Mizuma M, Rudek MA, Zhao M, Maitra A, Ray B. A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest. 2011;91:1383-1395. [PMID: 21691262 DOI: 10.1038/labinvest.2011.86] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
59 Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z, Shah SV, Zhang S, Zhang L, Zhuang X, Michalek S, Grizzle WE, Zhang HG. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009;50:1412-20. [PMID: 19708080 DOI: 10.1002/hep.23148] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 8.0] [Reference Citation Analysis]
60 Yan J, Teng F, Chen W, Ji Y, Gu Z. Cystathionine β-synthase-derived hydrogen sulfide regulates lipopolysaccharide-induced apoptosis of the BRL rat hepatic cell line in vitro. Exp Ther Med 2012;4:832-8. [PMID: 23226735 DOI: 10.3892/etm.2012.672] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
61 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 97] [Article Influence: 16.7] [Reference Citation Analysis]
62 Pelillo C, Bergamo A, Mollica H, Bestagno M, Sava G. Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin: CRC PROGRESSION AND LIVER MICROENVIRONMENT. J Cell Biochem 2015;116:2385-96. [DOI: 10.1002/jcb.25189] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
63 Zhang Z, Zhang JY, Wang LF, Wang FS. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2012;27:223-230. [PMID: 22004062 DOI: 10.1111/j.1440-1746.2011.06940.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
64 Wu Z, Han M, Chen T, Yan W, Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury: Acute liver failure. Liver International 2010;30:782-94. [DOI: 10.1111/j.1478-3231.2010.02262.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 150] [Article Influence: 13.5] [Reference Citation Analysis]
65 Wang Y, Wang W, Shen C, Wang Y, Jiao M, Yu W, Yin H, Shang X, Liang Q, Zhao C. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection. Sci Rep 2017;7:88. [PMID: 28273905 DOI: 10.1038/s41598-017-00221-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
66 Zhang J, Guo L, Liu M, Jing Y, Zhou S, Li H, Li Y, Zhao J, Zhao X, Karunaratna N, Jiang K, Zhou L, Wang B. Receptor-interacting protein kinase 3 mediates macrophage/monocyte activation in autoimmune hepatitis and regulates interleukin-6 production. United European Gastroenterol J 2018;6:719-28. [PMID: 30083334 DOI: 10.1177/2050640618756124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
67 Zhao J, Liu J, Pang X, Zhang X, Wang S, Wu D. Rosiglitazone attenuates angiotensin II-induced C-reactive protein expression in hepatocytes via inhibiting AT1/ROS/MAPK signal pathway. International Immunopharmacology 2016;31:178-85. [DOI: 10.1016/j.intimp.2015.12.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
68 Salunkhe SA, Chitkara D, Mahato RI, Mittal A. Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. Adv Drug Deliv Rev 2021;173:394-415. [PMID: 33831474 DOI: 10.1016/j.addr.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Safi SZ, Batumalaie K, Mansor M, Chinna K, Mohan S, Karimian H, Qvist R, Ashraf MA, Yan GO. Glutamine treatment attenuates hyperglycemia-induced mitochondrial stress and apoptosis in umbilical vein endothelial cells. Clinics (Sao Paulo) 2015;70:569-76. [PMID: 26247670 DOI: 10.6061/clinics/2015(08)07] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
70 Aller MA, Arias JL, García-Domínguez J, Arias JI, Durán M, Arias J. Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair. 2008;1:6. [PMID: 19014418 DOI: 10.1186/1755-1536-1-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
71 Kremer M, Son G, Zhang K, Moore SM, Norris A, Manzini G, Wheeler MD, Hines IN. Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression. Transpl Int 2014;27:748-58. [PMID: 24649805 DOI: 10.1111/tri.12322] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
72 Xie J, Zeng Q, Wang M, Ou X, Ma Y, Cheng A, Zhao XX, Liu M, Zhu D, Chen S, Jia R, Yang Q, Wu Y, Zhang S, Liu Y, Yu Y, Zhang L, Chen X. Transcriptomic Characterization of a Chicken Embryo Model Infected With Duck Hepatitis A Virus Type 1. Front Immunol 2018;9:1845. [PMID: 30197639 DOI: 10.3389/fimmu.2018.01845] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
73 Huang Z, Chen M, Zhang J, Sheng Y, Ji L. Integrative analysis of hepatic microRNA and mRNA to identify potential biological pathways associated with monocrotaline-induced liver injury in mice. Toxicol Appl Pharmacol 2017;333:35-42. [PMID: 28818515 DOI: 10.1016/j.taap.2017.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
74 Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN. HCV and oxidative stress in the liver. Viruses. 2013;5:439-469. [PMID: 23358390 DOI: 10.3390/v5020439] [Cited by in Crossref: 129] [Cited by in F6Publishing: 115] [Article Influence: 16.1] [Reference Citation Analysis]
75 Damgaard RB, Nachbur U, Yabal M, Wong WW, Fiil BK, Kastirr M, Rieser E, Rickard JA, Bankovacki A, Peschel C, Ruland J, Bekker-Jensen S, Mailand N, Kaufmann T, Strasser A, Walczak H, Silke J, Jost PJ, Gyrd-Hansen M. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 2012;46:746-58. [PMID: 22607974 DOI: 10.1016/j.molcel.2012.04.014] [Cited by in Crossref: 256] [Cited by in F6Publishing: 242] [Article Influence: 28.4] [Reference Citation Analysis]
76 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
77 Goulet O, Lambe C. Intravenous lipid emulsions in pediatric patients with intestinal failure: . Current Opinion in Organ Transplantation 2017;22:142-8. [DOI: 10.1097/mot.0000000000000396] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
78 Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr. 2013;56:461-468. [PMID: 23287807 DOI: 10.1016/j.numecd.2012.02.007] [Cited by in Crossref: 229] [Cited by in F6Publishing: 235] [Article Influence: 28.6] [Reference Citation Analysis]
79 Zhou JH, Lu X, Yan CL, Sheng XY, Cao HC. Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure. World J Stem Cells 2021; 13(3): 208-220 [PMID: 33815670 DOI: 10.4252/wjsc.v13.i3.208] [Reference Citation Analysis]
80 Dini L, Vergallo C. Environmental Factors Affecting Phagocytosis of Dying Cells:Smoking and Static Magnetic Fields. In: Krysko DV, Vandenabeele P, editors. Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Diseases. Dordrecht: Springer Netherlands; 2009. pp. 409-38. [DOI: 10.1007/978-1-4020-9293-0_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
81 Kostadinova L, Shive CL, Zebrowski E, Fuller B, Rife K, Hirsch A, Compan A, Moreland A, Falck-Ytter Y, Popkin DL, Anthony DD. Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy. Pathog Immun 2018;3:149-63. [PMID: 30370392 DOI: 10.20411/pai.v3i1.242] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
82 Dasarathy S. Inflammation and liver. JPEN J Parenter Enteral Nutr. 2008;32:660-666. [PMID: 18974249 DOI: 10.1177/0148607108324584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
83 Kimura S, Ozaki KS, Ueki S, Zhang M, Yokota S, Stolz DB, Geller DA, Murase N. Contribution of alloantigens to hepatic ischemia/reperfusion injury: Roles of natural killer cells and innate immune recognition of nonself. Liver Transpl. 2016;22:80-90. [PMID: 26335784 DOI: 10.1002/lt.24330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
84 Rosen HR. Transplantation immunology: what the clinician needs to know for immunotherapy. Gastroenterology. 2008;134:1789-1801. [PMID: 18471555 DOI: 10.1053/j.gastro.2008.02.062] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
85 Gil MN, Choi DR, Yu KS, Jeong JH, Bak DH, Kim DK, Lee NS, Lee JH, Jeong YG, Na CS, Na DS, Ryu KH, Han SY. Rhus verniciflua Stokes attenuates cholestatic liver cirrhosis-induced interstitial fibrosis via Smad3 down-regulation and Smad7 up-regulation. Anat Cell Biol 2016;49:189-98. [PMID: 27722012 DOI: 10.5115/acb.2016.49.3.189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
86 Wu X, Zhang JY, Huang A, Li YY, Zhang S, Wei J, Xia S, Wan Y, Chen W, Zhang Z. Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. J Infect Dis. 2013;208:1294-1304. [PMID: 23847059 DOI: 10.1093/infdis/jit312] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
87 An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012;86:1337-1348. [PMID: 22367091 DOI: 10.1007/s00204-012-0814-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
88 Wang FS, Zhang Z. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol. 2009;3:499-512. [PMID: 19817672 DOI: 10.1586/egh.09.50] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
89 Liu WC, Yang MC, Wu YY, Chen PH, Hsu CM, Chen LW. Lactobacillus plantarum reverse diabetes-induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase pathways. PLoS One 2018;13:e0196511. [PMID: 29851956 DOI: 10.1371/journal.pone.0196511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
90 Ramirez T, Longato L, Dostalek M, Tong M, Wands JR, de la Monte SM. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol Alcohol 2013;48:39-52. [PMID: 22997409 DOI: 10.1093/alcalc/ags106] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
91 Khoury T, Tzukert K, Abel R, Abu Rmeileh A, Levi R, Ilan Y. The gut-kidney axis in chronic renal failure: A new potential target for therapy: Gut microbiome in renal failure. Hemodialysis International 2017;21:323-34. [DOI: 10.1111/hdi.12486] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
92 Meng Z, Wang J, Yuan Y, Cao G, Fan S, Gao C, Wang L, Li Z, Wu X, Wu Z, Zhao L, Yin Z. γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice. Immunology 2017;151:43-55. [PMID: 28092402 DOI: 10.1111/imm.12712] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
93 Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51:81-91. [PMID: 19842207 DOI: 10.1002/hep.23273] [Cited by in Crossref: 275] [Cited by in F6Publishing: 279] [Article Influence: 25.0] [Reference Citation Analysis]
94 Zhang X, Meng Z, Qiu S, Xu Y, Yang D, Schlaak JF, Roggendorf M, Lu M. Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways. Cell Microbiol. 2009;11:1624-1637. [PMID: 19573162 DOI: 10.1111/j.1462-5822.2009.01353.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
95 Pizano-Martínez O, Yañez-Sánchez I, Alatorre-Carranza P, Miranda-Díaz A, Ortiz-Lazareno PC, García-Iglesias T, Daneri-Navarro A, Mercado MVD, Fafutis-Morris M, Delgado-Rizo V. YKL-40 expression in CD14+ liver cells in acute and chronic injury. World J Gastroenterol 2011; 17(33): 3830-3835 [PMID: 21987626 DOI: 10.3748/wjg.v17.i33.3830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
96 Renna MS, Figueredo CM, Rodríguez-galán MC, Icely PA, Cejas H, Cano R, Correa SG, Sotomayor CE. Candida albicans up-regulates the Fas-L expression in liver Natural Killer and Natural Killer T cells. Immunobiology 2015;220:1210-8. [DOI: 10.1016/j.imbio.2015.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Zhao J, Liu J, Pang X, Zhang X, Wang S, Wu D. Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes. Naunyn Schmiedebergs Arch Pharmacol 2016;389:1225-34. [PMID: 27492718 DOI: 10.1007/s00210-016-1279-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
98 Sundaram V, May FP, Manne V, Saab S. Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:1745-52.e2. [PMID: 24681081 DOI: 10.1016/j.cgh.2014.02.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
99 Vidal-Vanaclocha F. The prometastatic microenvironment of the liver. Cancer Microenviron. 2008;1:113-129. [PMID: 19308690 DOI: 10.1007/s12307-008-0011-6] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
100 Laverty HG, Antoine DJ, Benson C, Chaponda M, Williams D, Park BK. The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol 2010;66:961-76. [DOI: 10.1007/s00228-010-0862-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
101 Meshkani R, Vakili S. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clin Chim Acta. 2016;462:77-89. [PMID: 27570063 DOI: 10.1016/j.cca.2016.08.015] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 12.6] [Reference Citation Analysis]
102 Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G, Shen G. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Mol Immunol 2011;48:1573-7. [PMID: 21481941 DOI: 10.1016/j.molimm.2011.03.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
103 Mascia C, Vita S, Zuccalà P, Marocco R, Tieghi T, Savinelli S, Rossi R, Iannetta M, Pozzetto I, Furlan C, Mengoni F, Mastroianni CM, Vullo V, Lichtner M. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS One 2017;12:e0179400. [PMID: 28636655 DOI: 10.1371/journal.pone.0179400] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
104 Vierling JM. The Pathogenesis of Autoimmune Hepatitis. In: Hirschfield GM, Heathcote EJ, editors. Autoimmune Hepatitis. New York: Springer; 2012. pp. 3-49. [DOI: 10.1007/978-1-60761-569-9_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
105 Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245-257. [PMID: 20665377 DOI: 10.1055/s-0030-1255354] [Cited by in Crossref: 778] [Cited by in F6Publishing: 760] [Article Influence: 70.7] [Reference Citation Analysis]
106 Ma J, Guo X, Wu X, Li J, Zhu X, Li Z, Li J, Pan L, Li T, Li H, Liu Y. Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population. J Med Virol 2010;82:1501-7. [PMID: 20648603 DOI: 10.1002/jmv.21855] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
107 Bıçakçı E, Demirtaş CÖ, Çelikel Ç, Haklar G, Duman DG. Myeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of ınflammation and fibrosis in non-alcoholic steatohepatitis? Turk J Gastroenterol 2020;31:681-7. [PMID: 33169705 DOI: 10.5152/tjg.2020.19403] [Reference Citation Analysis]
108 Ganesan M, Natarajan SK, Zhang J, Mott JL, Poluektova LI, McVicker BL, Kharbanda KK, Tuma DJ, Osna NA. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde. Am J Physiol Gastrointest Liver Physiol 2016;310:G930-40. [PMID: 27056722 DOI: 10.1152/ajpgi.00021.2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
109 Xu D, Huang Y, Wang J. Gut microbiota modulate the immune effect against hepatitis B virus infection.Eur J Clin Microbiol Infect Dis. 2015;34:2139-2147. [PMID: 26272175 DOI: 10.1007/s10096-015-2464-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
110 Velazquez VM, Hon H, Ibegbu C, Knechtle SJ, Kirk AD, Grakoui A. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology. 2012;56:2071-2081. [PMID: 22711645 DOI: 10.1002/hep.25904] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
111 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 346] [Article Influence: 49.6] [Reference Citation Analysis]
112 Zhang S, Hou Y, Yang J, Xie D, Jiang L, Hu H, Hu J, Luo C, Zhang Q. Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure. J Cell Mol Med 2020;24:7082-93. [PMID: 32492261 DOI: 10.1111/jcmm.15290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
113 Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in drug-induced liver injury: Certainties and doubts. World J Gastroenterol 2009; 15(39): 4865-4876 [PMID: 19842215 DOI: 10.3748/wjg.15.4865] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
114 Yang L, Han Z, Tian L, Mai P, Zhang Y, Wang L, Li L. Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice. Sci Rep 2015;5:13423. [PMID: 26324256 DOI: 10.1038/srep13423] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
115 Ren J, Wang Y, Gao Y, Mehta SB, Lee CG. FAT10 mediates the effect of TNF-α in inducing chromosomal instability. J Cell Sci 2011;124:3665-75. [PMID: 22025632 DOI: 10.1242/jcs.087403] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
116 Al Mamun A, Akter A, Hossain S, Sarker T, Safa SA, Mustafa QG, Muhammad SA, Munir F. Role of NLRP3 inflammasome in liver disease. J Dig Dis 2020;21:430-6. [PMID: 32585073 DOI: 10.1111/1751-2980.12918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
117 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients. 2014;6:5583-5599. [PMID: 25479248 DOI: 10.3390/nu6125583] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
118 Horiguchi N, Lafdil F, Miller AM, Park O, Wang H, Rajesh M, Mukhopadhyay P, Fu XY, Pacher P, Gao B. Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology. 2010;51:1724-1734. [PMID: 20196117 DOI: 10.1002/hep.23532] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
119 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Lawrenczyk A, Kim S, Wen X, Xiong R, Yuan W. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment. Pathogens. 2014;3:563-576. [PMID: 25438012 DOI: 10.3390/pathogens3030563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]